Skip to main content

Evaluation of Erectile Disorder

  • Chapter
  • First Online:
The Textbook of Clinical Sexual Medicine
  • 2941 Accesses

Abstract

In this chapter we aim to review the contemporary knowledge regarding evaluation of erectile disorder. We used Medline search to review the English-language journal articles spanning the last 20 years with emphasis on the recent data, using the terms erectile dysfunction, evaluation, epidemiology (incidence/prevalence), etiology, pathophysiology, phenomenology/DSM-5 diagnostic criteria, and best practice or evidence-based approach for diagnosis including diagnostic tests, instruments, or rating scales. We used the entire original and review articles that met the criteria of inclusion and found to be relevant to the purpose of this chapter. Criteria included all pertinent review articles, randomized controlled trials with tight methodological design and a high level of evidence, cohort studies, and retrospective analyses. We also manually revised references from selected articles for additional relevant publications. We found several interesting studies and reviews that have addressed the new data regarding evaluation of erectile disorder. There is emerging information and novel technology available to improve our understanding regarding even the well-settled evaluation modalities for ED treatment. In conclusion, the current evaluation of ED is still far away from the ideal one. We expect to see new methods and technologies that may revolutionize pathophysiology, diagnosis, and treatment of ED especially in complex cases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. NIH Consensus Development Panel on Impotence. NIH consensus conference: impotence. JAMA. 1993;270:83–90.

    Article  Google Scholar 

  2. Lue TF. Physiology of penile erection and pathophysiology of erectile dysfunction. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell—Walsh urology. 10th ed. Philadelphia: Saunders Elsevier; 2007. p. 718–49.

    Google Scholar 

  3. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, Mckinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol. 1994;151:54–61.

    CAS  PubMed  Google Scholar 

  4. United States Bureau of Census 1992. Statistical abstract of the United States 112th ed. Washington, DC; 1992. p. 19.

    Google Scholar 

  5. Kleinman KP, Feldman HA, Johannes CB, Derby CA, McKinlay JB. A new surrogate variable for erectile dysfunction status in the Massachusetts male aging study. J Clin Epidemiol. 2000;53(1):71–8.

    Article  CAS  PubMed  Google Scholar 

  6. Brock G. Erectile dysfunction update education forum summary. Can J Urol. 2000;8:1416–8.

    Google Scholar 

  7. El-Sakka AI. Characteristics of erectile dysfunction in Saudi patients. Int J Impot Res. 2004;16:13–20.

    Article  CAS  PubMed  Google Scholar 

  8. El-Sakka AI. Association of risk factors and medical comorbidities with male sexual dysfunctions. J Sex Med. 2007;4:1691–700.

    Article  PubMed  Google Scholar 

  9. Seyam RM, Albakry A, Ghobish A, Arif H, Dandash K, Rashwan H. Prevalence of erectile dysfunction and its correlates in Egypt: a community-based study. Int J Impot Res. 2003;15:237–45.

    Article  CAS  PubMed  Google Scholar 

  10. Shaeer KZ, Osegbe DN, Siddiqui SH, Razzaque A, Glasser DB, Jaguste V. Prevalence of erectile dysfunction and its correlates among men attending primary care clinics in three countries, Pakistan, Egypt, and Nigeria. Int J Impot Res. 2003;Suppl 1:S8–S14.

    Article  Google Scholar 

  11. Ludwig W, Phillips M. Organic causes of erectile dysfunction in men under 40. Urol Int. 2014;92:1–6.

    Article  PubMed  Google Scholar 

  12. Shaeer O, Shaeer K. The global online sexuality survey (GOSS.): erectile dysfunction among Arabic-speaking internet users in the Middle East. J Sex Med. 2011;9:2152–63.

    Article  Google Scholar 

  13. Shaeer O, Shaeer K. The global online sexuality survey (GOSS). The United States of America in 2011. Chapter I. Erectile dysfunction among English-speakers. J Sex Med. 2012;9:3018–27.

    Article  PubMed  Google Scholar 

  14. Andersson KE, Wagner G. Physiology of penile erections [review]. Physiol Rev. 1995;75:191–236.

    CAS  PubMed  Google Scholar 

  15. Burnett AL. Nitric oxide in the penis: physiology and pathology. J Urol. 1997;157:320–4.

    Article  CAS  PubMed  Google Scholar 

  16. Lincoln TM. Cyclic GMP and mechanisms of vasodilation. Pharmacol Ther. 1989;41:479–502.

    Article  CAS  PubMed  Google Scholar 

  17. Saenz de Tejada I. Molecular mechanisms for the regulation of penile smooth muscle contractility. Int J Impot Res. 2000;12(Suppl 4):S34–8.

    Google Scholar 

  18. Stief CG, Uckert S, Becker AJ, Truss MC, Jonas U. The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo. J Urol. 1998;159(4):1390–3.

    Article  CAS  PubMed  Google Scholar 

  19. Saenz de Tejada I, Blanco R, Goldstein I, Azadzoi K, de las Morenas A, Krane RJ, et al. Cholinrergic neurotransmission in human corpus cavernosum. Response of isolated tissue. Am J Physiol. 1988;254(3 Pt 2):H459–67.

    Google Scholar 

  20. Giuliano F, Allard J. Apomorphine SL (Uprima): preclinical and clinical experiences learned from the first central nervous system-acting ED drug [review]. Int J Impot Res. 2002;14(Suppl 1):S53–6.

    Article  PubMed  Google Scholar 

  21. Mulligan T, Schmitt B. Testosterone for erectile failure. J Intern Med. 1993;8:517–21.

    CAS  Google Scholar 

  22. Fazio L, Brock G. Erectile dysfunction: management update. CMAJ. 2004;170(9):1429–37.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Bors E, Comar AE. Neurological urology: physiology of micturition, its neurological disorders and sequelae. Baltimore: University Park Press; 1971.

    Google Scholar 

  24. Siegel T, Moul JW, Spevak M, Alvord G, Costabile RA. The development of erectile dysfunction in men treated for prostate cancer. J Urol. 2001;165:430–5.

    Article  CAS  PubMed  Google Scholar 

  25. Brock GB, Lue TF. Drug-induced sexual dysfunction: an update. Drug Saf. 1993;8:414–26.

    Article  CAS  PubMed  Google Scholar 

  26. Al Khaja KA, Sequeira RP, Alkhaja AK, Damanhori AH. Antihypertensive drugs and male sexual dysfunction: a review of adult hypertension guideline recommendations. J Cardiovasc Pharmacol Ther. 2016 May;21(3):233–44.

    Article  CAS  PubMed  Google Scholar 

  27. La Torre A, Giupponi G, Duffy D, Conca A, Catanzariti D. Sexual dysfunction related to drugs: a critical review. Part IV: cardiovascular drugs. Pharmacopsychiatry. 2015;48(1):1–6.

    CAS  PubMed  Google Scholar 

  28. McVary KT, Carrier S, Wessells H. Subcommittee on smoking and erectile dysfunction socioeconomic committee, sexual medicine society of North America. Smoking and erectile dysfunction: evidence based analysis. J Urol. 2001;166(5):1624–32.

    Article  CAS  PubMed  Google Scholar 

  29. Huang YC, Chin CC, Chen CS, Shindel AW, Ho DR, Lin CS, Shi CS. Chronic cigarette smoking impairs erectile function through increased oxidative stress and apoptosis, decreased nNOS, endothelial and smooth muscle contents in a rat model. PLoS One. 2015;10(10):e0140728.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Grossmann M, Wu F. Male androgen deficiency: a multisystem syndrome. Asian J Androl. 2014;16(2):159–60.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Corona G, Rastrelli G, Monami M, Guay A, Buvat J, Sforza A, Forti G, Mannucci E, Maggi M. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol. 2011;165(5):687–701.

    Article  CAS  PubMed  Google Scholar 

  32. El-Sakka AI, Hassoba HM, Sayed HM, Tayeb KA. Pattern of endocrinal changes in patients with sexual dysfunction. J Sex Med. 2005;2(4):551–8.

    Article  CAS  PubMed  Google Scholar 

  33. Chung SD, Chen YK, Lin HC, Lin HC. Increased risk of stroke among men with erectile dysfunction: a nationwide population-based study. J Sex Med. 2011;8:240–6.

    Article  PubMed  Google Scholar 

  34. Kelly DM, Jones TH. Testosterone: a vascular hormone in health and disease. J Endocrinol. 2013;217(3):R47–71.

    Article  CAS  PubMed  Google Scholar 

  35. Corona G, Bianchini S, Sforza A, Vignozzi L, Maggi M. Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men. Hormones (Athens). 2015;14(4):569–78.

    Google Scholar 

  36. Caskurlu T, Tasci AI, Resim S, Sahinkanat T, Ergenekon E. The etiology of erectile dysfunction and contributing factors in different age groups in Turkey. Int J Urol. 2004;11:525–9.

    Article  PubMed  Google Scholar 

  37. Donatucci CF, Lue TF. Erectile dysfunction in men under 40: etiology and treatment choice. Int J Impot Res. 1993;5:97–103.

    CAS  PubMed  Google Scholar 

  38. Glina S, Sharlip ID, Hellstrom WJG. Modifying risk factors to prevent and treat erectile dysfunction. J Sex Med. 2013;10:115–9.

    Article  PubMed  Google Scholar 

  39. Ahmed I, El-Sakka A. Erectile dysfunction in Arab countries. Part I prevalence and correlates. Arab J Urol. 2012;10:97–103.

    Article  Google Scholar 

  40. Guo W, Liao C, Zou Y, Li F, Li T, Zhou Q, et al. Erectile dysfunction and risk of clinical cardiovascular events: a metaanalysis of seven cohort studies. J Sex Med. 2010;7:2805–16.

    Article  PubMed  Google Scholar 

  41. Araujo AB, Travison TG, Ganz P, Chiu GR, Kupelian V, Rosen RC, et al. Erectile dysfunction and mortality. J Sex Med. 2009;6:2445–54.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Banks E, Joshy G, Abhayaratna WP, Kritharides L, Macdonald RJ, Korda RJ, et al. Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study. PLoS Med. 2013;10:e1001372.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Yamada T, Hara K, Umematsu H, Suzuki R, Kadowaki T. Erectile dysfunction and cardiovascular events in diabetic men: a meta-analysis of observational studies. PLoS One. 2012;7:e43673.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Dong JY, Zhang YH, Qin LQ. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2011;58:1378–85.

    Article  PubMed  Google Scholar 

  45. El-Sakka AI, Morsy AM, Fagih BI, Nassar AH. Coronary artery risk factors in patients with erectile dysfunction. J Urol. 2004;172:251–4.

    Article  PubMed  Google Scholar 

  46. El-Sakka AI, Morsy AM. Screening for ischemic heart disease in patients with erectile dysfunction. The role of penile Doppler ultrasonography. Urology. 2004;64:346–50.

    Article  PubMed  Google Scholar 

  47. Jackson G, Montorsi P, Adams MA, Anis T, El-Sakka A, Miner M, et al. Cardiovascular aspects of sexual medicine. J Sex Med. 2010;7:1608–26.

    Article  PubMed  Google Scholar 

  48. Jackson G, Montorsi P, Adams MA, Anis T, El-Sakka A, Miner M, et al. Cardiovascular aspects of sexual medicine. In: Montorsi R, Basson R, Adaikan G, et al., editors. Sexual medicine, sexual dysfunctions in men and women. Paris, France: Health Publication Ltd; 2010. p. 351–402. [chapter VIII].

    Google Scholar 

  49. El-Sakka AI, Morsy AM, Fagih BI. Severity of erectile dysfunction could predict left ventricular diastolic dysfunction in patients without overt cardiac complaint. J Sex Med. 2011;8:2590–7.

    Article  PubMed  Google Scholar 

  50. Malavige LS, Jayaratne SD, Kathriarachchi ST, Sivayogan S, Ranasinghe P, et al. Erectile dysfunction is a strong predictor of poor quality of life in men with type 2 diabetes mellitus. Diabet Med. 2014;31:699–706.

    Article  CAS  PubMed  Google Scholar 

  51. El-Sakka AI, Tayeb KA. Erectile dysfunction risk factors in non-insulin dependent diabetic Saudi patients. J Urol. 2003;169:1043–7.

    Article  PubMed  Google Scholar 

  52. El-Sakka AI. Penile axial rigidity and Doppler ultrasonography parameters in patients with erectile dysfunction: association with type 2 diabetes. Urology. 2003;62:525–31.

    Article  PubMed  Google Scholar 

  53. El-Sakka AI, Tayeb KA. Peyronie’s disease in diabetic patients being screened for erectile dysfunction. J Urol. 2005;174:1026–30.

    Article  PubMed  Google Scholar 

  54. El-Sakka AI, Tayeb KA. Vascular impairment of erection in patients with diabetes and Peyronie’s disease: Is that accumulative? J Sex Med. 2009;6:1736–42.

    Article  PubMed  Google Scholar 

  55. El-Sakka AI, Sayed HM, Tayeb KA. Diabetes-associated androgen alteration in patients with erectile dysfunction. Int J Androl. 2008;31:602–8.

    Article  CAS  PubMed  Google Scholar 

  56. El-Sakka AI, Sayed HM, Tayeb KA. Androgen pattern in patients with type 2 diabetes associated erectile dysfunction: impact of metabolic control. Urology. 2009;74:552–60.

    Article  PubMed  Google Scholar 

  57. El-Sakka AI. Erectile dysfunction in Arab countries. Part I: prevalence and correlates. Arab J Urol. 2012;10(2):97–103.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Siroky M, Azadzoi K, Kloner M, Lue T, Shabsigh R, Burnett A, Steers W, Andersson K. Vasculogenic erectile dysfunction: newer therapeutic strategies. J Urol. 2003;170(2):S24–30.

    Article  PubMed  Google Scholar 

  59. Sommer F, Goldstein I, Korda JB. Bicycle riding and erectile dysfunction: a review. J Sex Med. 2010;7:2346–58.

    Article  PubMed  Google Scholar 

  60. Yao F, Huang Y, Zhang Y, Dong Y, Ma H, et al. Subclinical endothelial dysfunction and low-grade inflammation play roles in the development of erectile dysfunction in young men with low risk of coronary heart disease. Int J Androl. 2012;35:653–9.

    Article  CAS  PubMed  Google Scholar 

  61. Vercellotti GM, Moldow CF, Jacob HS. Complement, oxidants, and endothelial injury: how a bedside observation opened a door to vascular biology. J Clin Invest. 2012;122:3044–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Esper R, Nordaby R, Vilariño J, Paragano A, Cacharrón J, Machado R. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol. 2006;5:4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  63. Kun A, Kiraly I, Pataricza J, Marton Z, Krassoi I, Varro A, Simonsen U, Papp J, Pajor L. C-type natriuretic peptide hyperpolarizes and relaxes human penile resistance arteries. J Sex Med. 2008;5:1114–25.

    Article  CAS  PubMed  Google Scholar 

  64. Vlachopoulos C, Rokkas K, Ioakeimidis N, Stefanadis C. Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links. Eur Urol. 2007;52(6):1590–600.

    Article  CAS  PubMed  Google Scholar 

  65. Sáenz de T, Angulo J, Cellek S, Gonzalez-Cadavid N. Physiology of erectile function. J Sex Med. 2004;1:254–65.

    Article  Google Scholar 

  66. Chung E, De Young L, Brock GB. Penile duplex ultrasonography in men with Peyronie’s disease: is it veno-occlusive dysfunction or poor cavernosal arterial inflow that contributes to erectile dysfunction? J Sex Med. 2011;8:3446–51.

    Article  PubMed  Google Scholar 

  67. Miner MM, Seftel AD. Peyronie’s disease: epidemiology, diagnosis, and management. Curr Med Res Opin. 2014;30:113–20.

    Article  PubMed  Google Scholar 

  68. Rosen R, Catania J, Lue T, Althof S, Henne J, et al. Impact of Peyronie’s disease on sexual and psychosocial functioning: qualitative findings in patients and controls. J Sex Med. 2008;5:1977–84.

    Article  PubMed  Google Scholar 

  69. Mulhall JP, Bivalacqua TJ, Becher EF. Standard operating procedure for the preservation of erectile function outcomes after radical prostatectomy. J Sex Med. 2012;10:195–203.

    Article  PubMed  Google Scholar 

  70. Fowler CJ, Panicker JN, Emmanuel A. Pelvic organ dysfunction in neurological disease. Cambridge: Cambridge University Press; 2010. ISBN:9780521198318.

    Book  Google Scholar 

  71. Vodušek DB. Lower urinary tract and sexual dysfunction in neurological patients. Eur Neurol. 2014;72(1–2):109–15.

    Article  PubMed  Google Scholar 

  72. El-Sakka AI, Hassoba HM, Sayed HM, Tayeb KA. Pattern of endocrinal changes in patients with sexual dysfunction. J Sex Med. 2005;2:551–8.

    Article  CAS  PubMed  Google Scholar 

  73. Young J. Approach to the male patient with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2012;97:707–18.

    Article  CAS  PubMed  Google Scholar 

  74. Veronelli A, Masu A, Ranieri R, Rognoni C, Laneri M, et al. Prevalence of erectile dysfunction in thyroid disorders: comparison with control subjects and with obese and diabetic patients. Int J Impot Res. 2006;18:111–4.

    Article  CAS  PubMed  Google Scholar 

  75. Krassas GE, Tziomalos K, Papadopoulou F, Pontikides N, Perros P. Erectile dysfunction in patients with hyper and hypothyroidism: how common and should we treat? J Clin Endocrinol Metab. 2008;93:1815–9.

    Article  CAS  PubMed  Google Scholar 

  76. Reliability and Prevalence in the DSM-5 Field Trials, January 12, 2012 http://www.dsm5.org/Documents/ Reliability_and_Prevalence_in_DSM-5_Field_Trials_ 1–12-12.pdf

  77. “Highlights of changes from DSM-IV-TR to DSM-5” (PDF). American Psychiatric Association. May 17, 2013. Archived from the original (PDF) on 26 Feb 2015.

    Google Scholar 

  78. Papagiannopoulos D, Khare N, Nehra A. Evaluation of young men with organic erectile dysfunction. Asian J Androl. 2015;17(1):11–6. doi:10.4103/1008-682X.139253.. Review.

    Article  PubMed  Google Scholar 

  79. Morgentaler A, Khera M, Maggi M, Zitzmann M. Commentary: who is a candidate for testosterone therapy? A synthesis of international expert opinions. J Sex Med. 2014;11:1636–45.

    Article  CAS  PubMed  Google Scholar 

  80. El-Sakka AI, Lue TF. A rational approach to investigation of the sexually dysfunctional man. In: Morales A, editor. Erectile dysfunction: issues in current pharmacotherapy. Martin Dunitz; United Kingdom 1998. p. 49–69.

    Google Scholar 

  81. Lue TF, El-Sakka AI. Erectile dysfunction. In: Weiss RM, George NJR, O’Reilly PH, editors. Comprehensive urology. London, UK: Mosby Harcourt Sciences; 2001. p. 597–612.

    Google Scholar 

  82. Hatzichristou D, Rosen RC, Derogatis LR, Low WY, Meuleman EJH, Sadovsky R. Recommendations for the clinical evaluation of men and women with sexual dysfunction. United Kingdom J Sex Med. 2010;7:337–48.

    Google Scholar 

  83. Sikka SC, Hellstrom WJG, Brock G, Morales AM. Standardization of vascular assessment of erectile dysfunction. J Sex Med. 2013;10:120–9.

    Article  PubMed  Google Scholar 

  84. Bella AJ, Sener A, Foell K, Brock GB. Nonpalpable scarring of the penile septum as a cause of erectile dysfunction: an atypical form of Peyronie’s disease. J Sex Med. 2007;4:226–30.

    Article  PubMed  Google Scholar 

  85. Burnett A. Campbell-walsh urology. Evaluation and management of erectile dysfunction. Ch. 24. Philadelphia: Elsevier Inc.; 2011.

    Google Scholar 

  86. Walz J, Epstein JI, Ganzer R, Graefen M, Guazzoni G, Kaouk J, Menon M, Mottrie A, Myers RP, Patel V, Tewari A, Villers A, Artibani W. A Critical Analysis of the Current Knowledge of Surgical Anatomy of the Prostate Related to Optimisation of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy: An Update. Eur Urol. 2016 Aug;70(2):301-11

    Google Scholar 

  87. Weyne E, Mulhall J, Albersen M. Molecular pathophysiology of cavernous nerve injury and identification of strategies for nerve function recovery after radical prostatectomy. Curr Drug Targets. 2015;16(5):459–73.

    Article  CAS  PubMed  Google Scholar 

  88. Ralph D, McNicholas T. UK management guidelines for erectile dysfunction. Br Med J. 2000;321:499–503.

    Article  CAS  Google Scholar 

  89. Corona G, Petrone L, Mannucci E, Mansani R, Balercia G, et al. Difficulties in achieving vs maintaining erection: organic, psychogenic and relational determinants. Int J Impot Res. 2005;17:252–8.

    Article  CAS  PubMed  Google Scholar 

  90. Bivalacqua TJ, Usta MF, Champion HC, Kadowitz PJ, Hellstrom WJ. Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl. 2003;24:S17–37.

    Article  CAS  PubMed  Google Scholar 

  91. Canadian Urological Association Guidelines Committee. Erectile dysfunction practice guidelines. Can J Urol. 2002;9(4):1583–7.

    Google Scholar 

  92. Ralph D, McNicholas T. UK management guidelines for erectile dysfunction. BMJ. 2000;321:499–503.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Davis-Joseph B, Tiefer L, Melman A. Accuracy of the initial history and physical examination to establish the etiology of erectile dysfunction. Urology. 1995;45:498–502.

    Article  CAS  PubMed  Google Scholar 

  94. Chun J, Carson III CC. Physician–patient dialogue and clinical evaluation of erectile dysfunction. Urol Clin North Am. 2001;28(2):249–58.

    Article  CAS  PubMed  Google Scholar 

  95. Metz P, Bengtsson J. Penile blood pressure. Scand J Urol Nephrol. 1981;15:161.

    Article  CAS  PubMed  Google Scholar 

  96. Aitchison M, Aitchison J, Carter R. Is the penile brachial index a reproducible and useful measurement? Br J Urol. 1990;66:202–4.

    Article  CAS  PubMed  Google Scholar 

  97. de Wolfe VG. Non-invasive vascular evaluation. In: Montague DK, editor. Disorders of male sexual function. Chicago: Year Book Publishers; 1988. p. 44–59.

    Google Scholar 

  98. Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol. 1987;137:829–36.

    CAS  PubMed  Google Scholar 

  99. Pescatori ES, Hatzichristou DG, Namburi S, Goldstein I. A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: a hemodynamic study. J Urol. 1994;151:1209–16.

    CAS  PubMed  Google Scholar 

  100. Erdogru T, Kadioglu A, Cayan S, Tellaloglu S. Does the positive intracavernous papaverine test always indicate a normal penile vascular system? Eur Urol. 1997;31:323–8.

    CAS  PubMed  Google Scholar 

  101. Lue TF, Hricak H, Marich KW, Tanagho EA. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology. 1985;155:777–81.

    Article  CAS  PubMed  Google Scholar 

  102. Mueller SC, Lue TF. Evaluation of vasculogenic impotence. Urol Clin North Am. 1988;15:65–76.

    CAS  PubMed  Google Scholar 

  103. Quam JP, King BF, James EM, Lewis RW, Brakke DM, et al. Duplex and color Doppler sonographic evaluation of vasculogenic impotence. AJR Am J Roentgenol. 1989;153:1141–7.

    Article  CAS  PubMed  Google Scholar 

  104. Naroda T, Yamanaka M, Matsushita K, Kimura K, Kawanishi Y, et al. Clinical studies for venogenic impotence with color Doppler ultrasonography – evaluation of resistance index of the cavernous artery. Nihon Hinyokika Gakkai Zasshi. 1996;87:1231–5.

    CAS  PubMed  Google Scholar 

  105. Shamloul R. Peak systolic velocities may be falsely low in young patients with erectile dysfunction. J Sex Med. 2006;3:138–43.

    Article  PubMed  Google Scholar 

  106. Jarow JP, Pugh VW, Routh WD, Dyer RB. Comparison of penile duplex ultrasonography to pudendal arteriography. Variant penile arterial anatomy affects interpretation of duplex ultrasonography. Invest Radiol. 1993;28:806–10.

    Article  CAS  PubMed  Google Scholar 

  107. Rajfer J, Canan V, Dorey EJ, Mehringer CM. Correlation between penile angiography and duplex scanning of cavernous arteries in impotent men. J Urol. 1990;143:1128–30.

    CAS  PubMed  Google Scholar 

  108. Shabsigh R, Fishman IJ, Shotland Y, Karacan I, Dunn JK. Comparison of penile duplex ultrasonography with nocturnal penile tumescence monitoring for the evaluation of erectile impotence. J Urol. 1990;143:924–7.

    CAS  PubMed  Google Scholar 

  109. Knispel HH, Anderson R. Evaluation of vasculogenic impotence by monitoring of cavernous oxygen tension. J Urol. 1993;149:1276–9.

    CAS  PubMed  Google Scholar 

  110. Donatucci F, Lue TF. The combined intracavernous injection and stimulation test: diagnostic accuracy. J Urol. 1992;148:61–2.

    CAS  PubMed  Google Scholar 

  111. Michal V, Pospichal J. Phalloarteriography in the diagnosis of erectile impotence. World J Surg. 1978;2:239–48.

    Article  CAS  PubMed  Google Scholar 

  112. Philip F, Shishehbor M. Current state of endovascular treatment for vasculogenic erectile dysfunction. Curr Cardiol Rep. 2013;15(5):360. doi:10.1007/s11886-013-0360-8.. Review.

    Article  PubMed  Google Scholar 

  113. Kaneko K, De Mouy EH, Lee BE. Sequential contrast-enhanced MR imaging of the penis. Radiology. 1994;191:75–7.

    Article  CAS  PubMed  Google Scholar 

  114. Vargas HA, Donati OF, Wibmer A, Goldman DA, Mulhall JP, et al. Association between penile dynamic contrast-enhanced MRI-derived quantitative parameters and self-reported sexual function in patients with newly diagnosed prostate cancer. J Sex Med. 2014;11(10):2581–8.

    Article  PubMed  Google Scholar 

  115. Wespes E, Delcour C, Struyen J, Schulman CC. Cavernometry-cavernography: its role in organic impotence. Eur Urol. 1984;10:229–32.

    CAS  PubMed  Google Scholar 

  116. Rudnick J, Bodecker R, Weidner W. Significance of the intracavernosal pharmacological injection test, pharmacocaverno-sography, artificial erection and cavernosometry in the diagnosis of venous leakage. Urol Int. 1991;46:338–43.

    Article  CAS  PubMed  Google Scholar 

  117. Lue TF, Hricak H, Schmidt RA, Tanagho EA. Functional evaluation of penile veins by cavernosography in papaverine-induced erection. J Urol. 1986;135:479–82.

    CAS  PubMed  Google Scholar 

  118. Montague DK, Lakin MM. False diagnoses of venous leak impotence. J Urol. 1992;148:148–9.

    CAS  PubMed  Google Scholar 

  119. Bemelmans B, Hendrixkx L, Koldewijn E, Lemmens W. Comparision of biothesiometry and neurophysiological investigations for the clinical evaluation of patients with erectile dysfunction. J Urol. 1995;153:1483–6.

    Article  CAS  PubMed  Google Scholar 

  120. Kaneko S, Bradley WE. Penile electrodiagnosis. Value of bulbocavernosus reflex latency versus nerve conduction velocity of the dorsal nerve of the penis in diagnosis of diabetic impotence. J Urol. 1987;137:933–5.

    CAS  PubMed  Google Scholar 

  121. Amarenco G, Kerdraon J. Perineal electrophysiological studies in erectile dysfunctions. Study of 423 cases. Ann Med Interne (Paris). 1993;144:383–8.

    CAS  Google Scholar 

  122. Abicht JH. Testing the autonomic system. In: Jonas U, Thon WF, Stief CG, editors. Erectile dysfunction. Springer-Verlag: Berlin; 1991. p. 187–93.

    Chapter  Google Scholar 

  123. Daffertshofer M, Linden D, Syren M, Junemann K-P, Berlit P. Assessment of local sympathetic function in patients with erectile dysfunction. Int J Impot Res. 1994;6(4):213–25.

    CAS  PubMed  Google Scholar 

  124. Yiou R, De Laet K, Hisano M, Salomon L, Abbou CC, et al. Neurophysiological testing to assess penile sensory nerve damage after radical prostatectomy. J Sex Med. 2012;9:2457–66.

    Article  PubMed  Google Scholar 

  125. Wagner G, Gerstenberg T, Levin RJ. Electrical activity of corpus cavernosum during flaccidity and erection of the human penis: a new diagnostic method? J Urol. 1989;142:723–5.

    CAS  PubMed  Google Scholar 

  126. Djamilian M, Stief CG, Hartmann U, Jonas U. Predictive value of real-time RigiScan monitoring for the etiology of organogenic impotence. J Urol. 1993;149:1269–71.

    CAS  PubMed  Google Scholar 

  127. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536–59.

    Article  CAS  PubMed  Google Scholar 

  128. Seftel AD, Kathrins M, Niederberger C. Critical update of the 2010 endocrine society clinical practice guidelines for male hypogonadism: a systematic analysis. Mayo Clin Proc. 2015;90(8):1104–15.

    Article  PubMed  Google Scholar 

  129. Corona G, Petrone L, Paggi F, Lotti F, Boddi V, et al. Sexual dysfunction in subjects with Klinefelter’s syndrome. Int J Androl. 2010;33:574–80.

    CAS  PubMed  Google Scholar 

  130. Maggi M, Buvat J, Corona G, Guay A. Hormonal causes of male sexual dysfunctions and their management (Hyperprolactinemia, thyroid disorders, GH Disorders, and DHEA). J Sex Med. 2012;10:661–77.

    Article  PubMed  CAS  Google Scholar 

  131. Fischer C. Cycle of penile erection synchronous with dreaming sleep. Arch Gen Psychiatry. 1965;12:29–45.

    Article  Google Scholar 

  132. Karacan I. Clinical value of nocturnal penile erection in the prognosis of impotence. Med Aspects Hum Sex. 1970;4:27.

    Google Scholar 

  133. Morales A, Condra M, Heaton JP, Johnston B, Fenemore J. Diurnal penile tumescence recording in the etiological diagnosis of erectile dysfunction. J Urol. 1994;152:1111–4.

    CAS  PubMed  Google Scholar 

  134. Bradley WE, Timm GW, Gallagher JM, Johnson BK. New method for continuous measurement of nocturnal penile tumescence and rigidity. Urology. 1985;26:4–9.

    Article  CAS  PubMed  Google Scholar 

  135. Allen RP, Smolev JK, Engel RM, Brendler CB. Comparison of RigiScan and formal nocturnal penile tumescence testing in the evaluation of erectile rigidity. J Urol. 1993;149:1265–8.

    CAS  PubMed  Google Scholar 

  136. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11:319–26.

    Article  CAS  PubMed  Google Scholar 

  137. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.

    Article  CAS  PubMed  Google Scholar 

  138. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain on the International Index of erectile function. Urology. 1999;54:346–51.

    Article  CAS  PubMed  Google Scholar 

  139. Derby CA, Araujo AB, Johannes CB, Feldman HA, McKinlay JB. Measurement of erectile dysfunction in population-based studies: the use of a single question self assessment in the Massachusetts Male Aging Study. Int J Impot Res. 2000;12:197–204.

    Article  CAS  PubMed  Google Scholar 

  140. Cappelleri JC, Siegel RL, Glasser DB, Osterloh IH, Rosen RC. Relationship between patient self-assessment of erectile function and the sexual health inventory for men. Clin Ther. 2001;23:1707–19.

    Article  CAS  PubMed  Google Scholar 

  141. Jardin A, Wagner G, Khoury S, et al. Recommendations of the 1st international consultation on erectile dysfunction. In: Jardin A, Wagner G, Khoury S, et al., editors. Erectile dysfunction. Plymouth, U.K: Health Publication Ltd; 2000. p. 711–26.

    Google Scholar 

  142. The Process of Care Consensus Panel. A process of care model for evaluation and treatment of erectile dysfunction. Int J Impot Res. 1999;11:11–9.

    Google Scholar 

  143. Rosen RC, Cappelleri JC, Gendrano III. N. The international index of erectile function (IIEF): a state-of-the science review. Int J Impot Res. 2002;14(4):226–44.

    Article  CAS  PubMed  Google Scholar 

  144. Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, Ader D, Fries JF, Bruce B, Rose M, PROMIS Cooperative Group. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmapcooperative group during its first two years. Med Care. 2007;45(5 Suppl 1):S3–S11.

    Article  PubMed  PubMed Central  Google Scholar 

  145. Weinfurt KP, Lin L, Bruner DW, Cyranowski JM, Dombeck CB, Hahn EA, Jeffery DD, Luecht RM, Magasi S, Porter LS, Reese JB, Reeve BB, Shelby RA, Smith AW, Willse JT, Flynn KE. Development and initial validation of the PROMIS(®) sexual function and satisfaction measures version 2.0. J Sex Med. 2015;12(9):1961–74. doi:10.1111/jsm.12966.. Epub 2015 Sep 7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmed I. El-Sakka .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

El-Sakka, A.I. (2017). Evaluation of Erectile Disorder. In: IsHak, W. (eds) The Textbook of Clinical Sexual Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-52539-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52539-6_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52538-9

  • Online ISBN: 978-3-319-52539-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics